A ‘shark tank’ review process will help determine the winner. Contenders pitch and defend their technologies to our sharks—a panel of experts. The voting system will also include audience participation.

The ‘innovation track’ at this year’s TCT includes:

  • Innovative Concepts, Diagnostics, and Therapies (2 sessions)
  • 'Shark Tank' Competition
  • Late-Breaking Early Feasibility and First-in-Human Clinical Studies

Over the past year, the launch of SCI’s  page has been successful largely due to the robust interaction with you. We appreciate your input as we build on that success and continue to keep the page relevant, insightful and consequential.

Lastly, the Skirball Center for Innovation will host soccer legend Carlo Ancelotti in an evening event on October 13th. Coach Ancelotti will touch on many innovation-centered themes in his discussion.

We look forward to seeing you in San Francisco in 3 weeks!

All the best, 
Juan F. Granada, MD
Executive Director and Chief Innovation Officer
CRF Skirball Center for Innovation




Legendary European soccer coach Carlo Ancelotti will spend a very special evening with us at 8:30pm on Tuesday, October 13, at the Hilton San Francisco Union Square, Grand Ballroom B. Coach Ancelotti will touch on a number of subjects, including the techniques he employed to motivate and optimize the abilities of players, from juniors to seasoned professionals with contracts worth hundreds of millions of dollars. Ancelotti has enjoyed success at every level of competition, and his experiences far transcend sport.




CRF Interventional Innovation Award Competition: The Innovation Award process began months ago, when CRF issued a ‘Call for Science’ on the TCT 2015 website. After the submission deadline passed, eight technologies were chosen from the pool of entrants. The 'Shark Tank' audience and a select panel will choose two finalists, with the winning technology presented in the Main Arena on Thursday, October 15.


‘Shark Tank’ Judges at TCT
Nine experts with diverse experience will serve as judges for TCT 2015 Innovation ‘Shark Tank’ Competition, which takes place Tuesday, October 13 from 8am - 12pm. These experts will vet the technologies in a robust Q&A format. The judges are:

  • Louis A. Cannon, MD, Program Director, McLaren Northern Michigan, Heart & Vascular Institute Cardiac & Vascular Research Center and McLaren Northern Michigan, Petoskey, Michigan

  • Peter J. Fitzgerald, MD, PhD, Professor of Medicine, Stanford University Medical Center, Stanford, CA

  • Juan F. Granada, MD, Executive Director & Chief Innovation Officer, CRF Skirball Center for Innovation, Orangeburg, NY

  • Frank Litvack, MD, Professor of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA

  • Chaim S. Lotan, MD, Director, Cardiology Division, Hadassah University Hospital, Jerusalem, Israel

  • Antoine Papiernik, Managing Partner, Sofinnova Partners, Paris, France

  • Martin T. Rothman, MD, MB, ChB, Vice President of Medical Affairs for coronary and peripheral vascular business, Medtronic CardioVascular, Santa Rosa, CA

  • Ron Waksman, MD, Director, Cardiovascular Research and Advanced Education, MedStar Heart & Vascular Institute, Washington, DC

  • Tamir Wolf, MD, PhD, Senior Director, Clinical Trials Center, Cardiovascular Research Foundation, New York, NY



Interactive Training Center

As part of the Innovative Agenda at TCT 2015, CRF brings back the Interactive Technology Center. The sessions will run Monday and Tuesday from 9am-12pm and Wednesday from 9am- 2pm at the ITC and Demonstration Theater. Subjects covered include LAA, MitraClip, TAVR, and Complex PCI Technologies.

  • Monday, October 12, 2015
    ITC and Demonstration Theater - LAA and MitraClip

  • Tuesday, October 13, 2015
    ITC and Demonstration Theater - TAVR

  • Wednesday, October 14, 2015
    ITC and Demonstration Theater - Complex PCI Technologies








Video Flashback: TCT 2014

SCI Executive Director Dr. Granada moderated a discussion at last year’s TCT on transition points in interventional cardiology innovation with legal expert Casey McGlynn, researcher Peter Fitzgerald, and device executive Dale Wahlstrom.

J. CASEY McGLYNN is a partner at Wilson Sonsini Goodrich & Rosati, a global law firm focusing primarily on technology, life sciences, and other growth enterprises.
PETER J. FITZGERALD, MD, PHD, is a Professor of Medicine at Stanford University Medical Center and a longstanding TCT faculty member. He is also one of the ‘sharks’ in this year’s tank.
DALE WAHLSTROM is the President and CEO of Act 3, LLC, focusing on medical innovation. He previously was President and CEO of LifeScience Alley, founded the BioBusiness Alliance in 2004, and enjoyed a 24-year career at Medtronic.